Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis

BACKGROUND: Renal anemia is a severe complication of chronic kidney disease (CKD) and may worsen its prognosis. Roxadustat is the only oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that has been proved effective to treat renal anemia. However, effects of roxadustat on non-dial...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Transl Med
Huvudupphovsmän: Jia, Linpei, Dong, Xingtong, Yang, Jingyan, Jia, Rufu, Zhang, Hongliang
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989965/
https://ncbi.nlm.nih.gov/pubmed/32042736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.12.18
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk